Comparison between Beximco

Pharmaceuticals & GlaxoSmithKline:

Liquidity Ratio

Current Ratio:
By comparing both the companies ratio we can found to know that
Beximco Pharmaceuticals is more liquid than compared to
GlaxoSmithKline.

Quick Ratio:
By comparing both the companies ratio it is evident that the
liquidity position of GlaxoSmithKline is better than that of the
Beximco Pharmaceuticals.

Cash Ratio:
While comparing the ratios of both the companies we found that the
cash ratio of GlaxoSmithKline was higher compared to Beximco
Pharmaceuticals, which means that GlaxoSmithKline was more
efficient in covering its current liability with cash.

NWC to Total Asset Ratio:

By comparing the ratios of both the companies we came to know
that the net working capital of Beximco Pharmaceuticals was higher
compared to GlaxoSmithKline.

Financial Leverage Ratio

Total Debt Ratio:

By comparing both the companies ratio we can say that
GlaxoSmithKline has a higher debt ratio compared to Beximco
Pharmaceuticals. Therefore, Beximco Pharmaceuticals is less risky
than compared to GlaxoSmithKline.

Debt/Equity Ratio:
By comparing both the companies ratio we can say that the debt
/equity ratio of GlaxoSmithKline is higher than compared to Beximco
Pharmaceuticals. So, GlaxoSmithKline has got enough money to pay
outs its debt.

Equity Multiplier:
While comparing the ratios of both the companies we found that the
equity multiplier of GlaxoSmithKline is way far better than compared
to Beximco Pharmaceuticals. The shareholders financed
GlaxoSmithKline more compared to Beximco Pharmaceuticals.
Activity Ratio

Receivable Turnover:
By comparing both companies ratio we can say that till 2013
GlaxoSmithKline was more efficient than Beximco Pharmaceuticals
but in 2014 Beximco Pharmaceuticals became more efficient in
collecting its outstanding credits accounts and reinvestment.

Inventory Turnover:
While comparing both the companies ratio we came to know that
GlaxoSmithKlines ability of selling and replacing its inventory was a
bit more effective and efficient from the very beginning compared to
Beximco Pharmaceuticals but in 2014 it become more efficient & far
better than ever before.

Total Asset Turnover:

By comparing both the companies ratio we can say that
GlaxoSmithKline was generating more profit than for every tk.1 in
asset than Beximco Pharmaceuticals.

Fixed Asset Turnover:

While comparing the ratios of both the companies we came to know
that the fixed asset turnover of GlaxoSmithKline is way far better
utilizing their asset efficiently than compared to Beximco
Pharmaceuticals.

NWC Turnover:
The comparison of net working capital turnover ratios of both the
companies tells us that GlaxoSmithKline is better in utilizing its
working capital effectively compared to Beximco Pharmaceuticals.

Profitability Ratio

Profit Margin on Sales:

By comparing both companies ratio we can say that Beximco
Pharmaceuticals is generating more profit than GlaxoSmithKline for
every tk. 1 in sales.

Rate of Return on Asset:

During our comparison we found that the rate of return on asset was
interestingly higher in GlaxoSmithKline compared to Beximco
Pharmaceuticals. Which means that GlaxoSmithKline was generating
more profit for every tk.1 is asset.

Rate of Return Equity:

By comparing both the companies ratio we can say that
GlaxoSmithKline is generating more profit than Beximco
Pharmaceuticals for every tk.1 in equity from 2009 till 2014.

Earnings Per Share:

By comparing both companies ratio we can say that
GlaxoSmithKline EPS is far better than Beximco Pharmaceuticals.

Payout Ratio:
By comparing both companies ratio we came to know that
GlaxoSmithKline has given more dividend than Beximco
Pharmaceuticals.